April 23, 2024

New Drug Application of Zydus’ innovative drug Desidustat tablets by China Medical System Holdings Limited accepted in China

by

New Drug Application of Zydus’ innovative drug Desidustat tablets by China Medical System Holdings Limited accepted in China

Please follow and like us:

Related posts:

No related posts.

Tags:

Comments are closed.

You may also like

July 19, 2024
by

Wipro Q1: Cons PAT at ₹3,037 cr, revenue at ₹21,964 cr Wipro Q1: Cons PAT up 6.2% QoQ; revenue down 1.1% Here are the IT services segment revenues, voluntary attrition and large deal bookings Wipro guidance: Expect revenue from IT services segment to be in the range of $2,600-2,652 mn FinancialNews #StockMarket #Investment #Trading Wipro Q1: Cons PAT at ₹3,037 cr, revenue at ₹21,964 cr Wipro Q1: Cons PAT up 6.2% QoQ; revenue down 1.1% Here are the IT services segment revenues, voluntary attrition and large deal bookings Wipro guidance: Expect revenue from IT services segment to be in the range of $2,600-2,652 mn FinancialNews #StockMarket #Investment #Trading

Wipro Q1: Cons PAT at ₹3,037 cr, revenue at ₹21,964 cr Wipro Q1: Cons PAT up 6.2% QoQ; revenue down...

Exit mobile version